ASX Announcement – Appointment of W&S

Felix Sperm Seperation Device

W&S has been working closely with a new customer, Memphasys, a publically listed startup medical device company to commercialise their innovative new product.
Memphasys' Felix device is set to revolutionise the IVF market space.

Commenting on the appointment, Memphasys Executive Chair, Alison Coutts said:

“The appointment of W&S Plastics, who have a high level of experience in the design and manufacturing of intricate components of medical devices, is a key milestone for Memphasys as we look to realise our commercialisation goals in 2020.”

Click here to read what Tech Invest Magazine has to say about this product and the W&S - Memphasys relationship

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.